Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time

Author(s):  Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R

Issue:  Sep/Oct 2012 - Volume 16, Number 5
View All Articles in Issue

Page(s):  431-433

Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Page 1
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Page 2
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Page 3

Download in electronic PDF format for $75

Abstract:  PhaSeal is a closed-system drug transfer device which has demonstrated to protect against occupational exposure to antineoplastic agents. Our aim was to assess the impact of the incorporation of PhaSeal on the processing time of chemotherapy. The study was a prospective simulation study which compared the processing times with the traditional open-system technique and using the closed-transfer system. Four experienced pharmacy technicians prepared six batches with each method simulating simple chemotherapy admixture operations. We compared the mean times obtained by student's t test and evaluated the “learning effect” between days by ANOVA. The average percentage of time saving with PhaSeal was 31.7% (time per batch [mean±SD] 6.44+0.73 vs. 9.44+0.98 minutes). Mean difference was statistically significant (3.0 min IC95% 2.50-3.50; p>0.0001). No significant learning curve effect was detected. The BD Medical/Carmel Pharma PhaSeal system, in addition to its protective properties, is able to save time in the elaboration process which leads to organization advantages for hospital pharmacy services.

Related Keywords: J. Sanchez-Rubio Ferrandez, PhD Pharmacy, M. C. Lozano, PhD Pharmacy, I. Iglesias, PhD Pharmacy, L. Sanchez-Rubio Ferrandez, PhD Pharmacy, B. Rodriguez Vargas, PhD Pharmacy, R. Moreno Diaz, PhD Pharmacy, closed-system drug transfer, chemotherapy agents, occupational exposure, preparation time

Related Categories: CANCER AND AIDS, PEER-REVIEWED, TECHNOLOGY, PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time
Sanchez-Rubio Ferrandez J
, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
Sep/Oct 2012
Pg. 431-433

Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Garrigue Philippe
, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
Mar/Apr 2016
Pg. 148-154

Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon
, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Jan/Feb 2018
Pg. 7-16

Art of Pharmacy v. State
Standridge Rob
May/Jun 2022
Pg. 182-186

PreScription: Compounding Pharmacy Issues for 2017
Allen Loyd V Jr
Jan/Feb 2017
Pg. 4

The BPS Pharmacy Specialty Certification Program
Bertin Richard J
May/Jun 1999
Pg. 200-203

Regulatory and Operational Issues of Founding a Compounding Pharmacy
Smith Lisa K
Nov/Dec 2002
Pg. 434-437

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance
Grilli Anthony
, Sutton Scott
Jan/Feb 2015
Pg. 30-37

Metro Atlanta Board - Certified Specialists' Attitudes Toward Compounding Pharmacy
Greenburg Aimee R
, Barnett Candace W
Jan/Feb 2004
Pg. 65-72

Legal & Ethical Issues for Pharmacy Websites
King LD
, Brashares Jennifer
Mar/Apr 2003
Pg. 88-92

Wish You Were Here: The History of Pharmacy Museum at the Arizona College of Pharmacy, Tucson, Arizona
Worthen Dennis B
Mar/Apr 2002
Pg. 116-117

PostScription: Innovative Community Pharmacy Practice: Past, Present, and Future
Huffman D C
Jul/Aug 2010
Pg. 350-351

Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
Sep/Oct 2016
Pg. 367-374

Applying Quality of Design Concepts to Pharmacy Compounding
Timko Robert J
Nov/Dec 2015
Pg. 453-463

Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
Sep/Oct 2020
Pg. 356

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Jan/Feb 2022
Pg. 72-79

Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Taghi Hassanien Sagban
, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Jul/Aug 2023
Pg. 340-346

A "North Star" for Pharmacy Compounders
Brunner Scott
Mar/Apr 2020
Pg. 110-113

Return to Top